Bernd Hoppe
Direttore/Membro del Consiglio presso Oxalosis & Hyperoxaluria Foundation
Profilo
Bernd Hoppe is currently the Director at Oxalosis & Hyperoxaluria Foundation.
Previously, he worked as the Vice President-Global Medical Affairs at Dicerna Pharmaceuticals, Inc.
Posizioni attive di Bernd Hoppe
Società | Posizione | Inizio |
---|---|---|
Oxalosis & Hyperoxaluria Foundation
Oxalosis & Hyperoxaluria Foundation Medical/Nursing ServicesHealth Services The Oxalosis & Hyperoxaluria Foundation is dedicated to eradicating all forms of hyperoxaluria disease forever. The non-profit company is based in New York, NY. The company's vision is a world without hyperoxaluria, and they are committed to improving the daily lives of people with this condition. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Bernd Hoppe
Società | Posizione | Fine |
---|---|---|
DICERNA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Oxalosis & Hyperoxaluria Foundation
Oxalosis & Hyperoxaluria Foundation Medical/Nursing ServicesHealth Services The Oxalosis & Hyperoxaluria Foundation is dedicated to eradicating all forms of hyperoxaluria disease forever. The non-profit company is based in New York, NY. The company's vision is a world without hyperoxaluria, and they are committed to improving the daily lives of people with this condition. | Health Services |
- Borsa valori
- Insiders
- Bernd Hoppe